Ju Kon Kim

Corporate Officer/Principal at Myongji University

Consumer Services

Health Technology

Profile

Ju Kon Kim is currently the Head of the Biology Department at Myongji University, a position he has held since 1995.
Prior to this, he worked as a Research Scientist at Seoul National University from 1979 to 1995.
He also served as the Chief Scientific Officer at GreenGene BioTech, Inc. Additionally, he earned a doctorate degree from Cornell University in 1990, an undergraduate degree from Seoul National University in 1977, and a graduate degree from Korea Advanced Institute of Science & Technology in 1979.

Ju Kon Kim active positions

Companies	Position	Start
Myongji University	Corporate Officer/Principal	2011-04-28

All active positions of Ju Kon Kim

Former positions of Ju Kon Kim

Companies	Position	End
Seoul National University	Chief Tech/Sci/R&D Officer	1994-12-31
GreenGene BioTech, Inc. GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea.	Chief Tech/Sci/R&D Officer	-

See the detail of Ju Kon Kim's experience

Training of Ju Kon Kim

Seoul National University	Undergraduate Degree
Korea Advanced Institute of Science & Technology	Graduate Degree
Cornell University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ju Kon Kim's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
GreenGene BioTech, Inc. GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea.	Health Technology